Tech Company Financing Transactions
Vektor Medical Funding Round
On 2/5/2024, Vektor Medical landed $16 million in Series A financing from Solas Bioventures, TVM Capital and private investors.
Transaction Overview
Company Name
Announced On
2/5/2024
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Series A
Investors
Solas Bioventures (Lead Investor)
TVM Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds for the commercialization of vMap®, Vektor's AI-based arrhythmia analysis tool.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
9255 Towne Centre Drive 750
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
We are advancing care for arrhythmia patients by unlocking insights contained in a standard ECG. vMap is an AI-based arrhythmia analysis tool, created to improve cardiac ablation outcomes, optimize workflows and increase procedural efficiency. Cardiac arrhythmias cause 10% of global deaths and over 25% of adults over 40 will develop a serious arrhythmia.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rob Krummen
Chief Financial Officer
Doug Komen
Chief Technical Officer
Christian Márton
Chief Technical Officer
Chris Villongco
Vice President
Maurice Pirio
VP - Bus. Development
Joe Braidwood
VP - Bus. Development
Lana Caron
VP - Marketing
Emily Lovell
VP - Product Management
Averee Chang
Browse more venture capital transactions:
Prev: 2/5/2024: Traive venture capital transaction
Next: 2/5/2024: Procyrion venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs